PTK2 and lung carcinoma: However, there was no association between FAK overexpression and survival in colorectal cancer (HR = 1.569, 95% CI:0.981–2.509, p = 0.060), lung cancer (HR = 1.694, 95% CI: 0.719–3.993, p = 0.228), breast cancer (HR = 2.286, 95% CI: 0.423–12.357, p = 0.337), bile duct cancer (HR = 1.995, 95% CI: 0.956–4.164, p = 0.066), and pancreatic cancer (HR = 0.948, 95% CI: 0.587–1.530, p = 0.827).